Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Conditions
Healthy
Interventions
DRUG

low dose

efavirenz single dosing once daily

DRUG

normal dose

efavirenz once daily

DRUG

low dose

Efavirenz single dosing once daily

Trial Locations (1)

Unknown

1220.20.41001 Boehringer Ingelheim Investigational Site, Basel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY